spirinolactone

What’s New in Pediatric Acne? Stop Picking and Start Applying Well-Tolerated Retinoids!
PEDIATRIC ACNE
by Jacqueline McKesey, MD, MS on
Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System, lead us through “Acne across the ages” at the 17th Annual Women’s and Pediatric Dermatology Seminar. She busted through several acne myths, which are easily debunked with new acne medications: Clascoterone 1% cream: it reduces sebum production in the skin! Similar to spironolactone, it is an anti-andr …

Continue reading "What’s New in Pediatric Acne? Stop Picking and Start Applying Well-Tolerated Retinoids!"

Clascoterone Cream | Therapeutic Cheat Sheet
clascoterone
by Kamaria Nelson, MD on
Clascoterone cream is a novel topical therapeutic agent used to treat acne vulgaris through androgen inhibition. Other androgen inhibitors such as combined oral contraceptive pills and off-label spironolactone can lead to some unwanted side effects such as feminization, gynecomastia, and erectile dysfunction, making them unsuitable for male patients. Unlike other androgen inhibitors used to manage …

Continue reading "Clascoterone Cream | Therapeutic Cheat Sheet"

Hormonal Treatment of Acne: Work up, Indications, & Guidelines
Hormonal treatment of acne
by Emily Murphy, MD on
Dr. Diane Thiboutot, Professor of Dermatology at The Pennsylvania State University College of Medicine, gave a practical talk at the 2022 ODAC Dermatology, Aesthetic and Surgical Conference about hormonal treatment of acne. Dr. Thiboutot discussed the hormonal work up, indications for hormonal treatment, and guidelines for choosing a therapy, including oral contraceptives. Hormonal Workup for Ac …

Continue reading "Hormonal Treatment of Acne: Work up, Indications, & Guidelines"

JDD Issue Highlights | April 2022
psoriasis
by NEXT STEPS IN DERM TEAM on
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …

Continue reading "JDD Issue Highlights | April 2022"

Paradigm Shifts in Lab Monitoring
Lab Monitoring
by Edita Newton, MD on
How to Mitigate Risk without Compromising Care If you were to counsel a patient on every possible risk of a given medication, it would be a long list of extreme and rare potential outcomes and almost certainly leave the patient in doubt whether it is safe even to take. Frequent lab monitoring has been common practice and often used to reduce the perception of risk with systemic medication …

Continue reading "Paradigm Shifts in Lab Monitoring"